Duquesne Family Office’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.1M	Buy	832,175 +31,815	+4%	+$576K	0.37%	50
2025 Q1	$16.4M	Buy	800,360 +512,825	+178%	+$10.5M	0.54%	36
2024 Q4	$7.39M	Hold	287,535	–	–	0.2%	59
2024 Q3	$4.77M	Buy	+287,535	New	+$4.77M	0.16%	62